233 related articles for article (PubMed ID: 36170029)
1. Pan-cancer analysis of a novel indicator of necroptosis with its application in human cancer.
Liu A; Li Y; Shen L; Li N; Shen L; Li Z
Aging (Albany NY); 2022 Sep; 14(18):7587-7616. PubMed ID: 36170029
[TBL] [Abstract][Full Text] [Related]
2. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment.
Hsu SK; Li CY; Lin IL; Syue WJ; Chen YF; Cheng KC; Teng YN; Lin YH; Yen CH; Chiu CC
Theranostics; 2021; 11(18):8813-8835. PubMed ID: 34522213
[TBL] [Abstract][Full Text] [Related]
3. Programmed Cell Death Tunes Tumor Immunity.
Liu J; Hong M; Li Y; Chen D; Wu Y; Hu Y
Front Immunol; 2022; 13():847345. PubMed ID: 35432318
[TBL] [Abstract][Full Text] [Related]
4. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.
Gao W; Wang X; Zhou Y; Wang X; Yu Y
Signal Transduct Target Ther; 2022 Jun; 7(1):196. PubMed ID: 35725836
[TBL] [Abstract][Full Text] [Related]
5. MLKL and other necroptosis-related genes promote the tumor immune cell infiltration, guiding for the administration of immunotherapy in bladder urothelial carcinoma.
Zhong B; Wang Y; Liao Y; Liang J; Wang K; Zhou D; Zhao Y; Jiang N
Apoptosis; 2023 Jun; 28(5-6):892-911. PubMed ID: 37000317
[TBL] [Abstract][Full Text] [Related]
6. Pan-cancer analyses of pyroptosis with functional implications for prognosis and immunotherapy in cancer.
Liu A; Shen L; Li N; Shen L; Li Z
J Transl Med; 2022 Mar; 20(1):109. PubMed ID: 35246158
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer.
Zhuang L; Sun Q; Huang S; Hu L; Chen Q
Sci Rep; 2023 Mar; 13(1):3877. PubMed ID: 36890219
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.
Tang R; Xu J; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
J Hematol Oncol; 2020 Aug; 13(1):110. PubMed ID: 32778143
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a novel indicator of pyroptosis regulated gene transcription level and its application in pan-cancer.
Xu JZ; Xia QD; Sun JX; Liu CQ; Lu JL; Xu MY; An Y; Xun Y; Liu Z; Hu J; Li C; Wang SG
Sci Rep; 2023 Oct; 13(1):17911. PubMed ID: 37863886
[TBL] [Abstract][Full Text] [Related]
10. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
[TBL] [Abstract][Full Text] [Related]
11. Pan-Cancer analyses of Necroptosis-Related genes as a potential target to predict immunotherapeutic outcome.
Zhou Z; Wu J; Ma W; Dong F; Wang J
J Cell Mol Med; 2023 Jan; 27(2):204-221. PubMed ID: 36583248
[TBL] [Abstract][Full Text] [Related]
12. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies.
Woo Y; Lee HJ; Jung YM; Jung YJ
Cells; 2020 Dec; 9(12):. PubMed ID: 33348858
[TBL] [Abstract][Full Text] [Related]
13. Ferroptosis, necroptosis, and pyroptosis in cancer: Crucial cell death types in radiotherapy and post-radiotherapy immune activation.
Wang Y; Wang Y; Pan J; Gan L; Xue J
Radiother Oncol; 2023 Jul; 184():109689. PubMed ID: 37150447
[TBL] [Abstract][Full Text] [Related]
14. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
Front Immunol; 2022; 13():968165. PubMed ID: 36389725
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC.
Niu X; Chen L; Li Y; Hu Z; He F
Semin Cancer Biol; 2022 Nov; 86(Pt 3):273-285. PubMed ID: 35288298
[TBL] [Abstract][Full Text] [Related]
16. Multi-omics analysis reveals the panoramic picture of necroptosis-related regulators in pan-cancer.
Li G; Wang X; Liu Y; Li H; Mu H; Zhang Y; Li Q
Aging (Albany NY); 2022 Jun; 14(12):5034-5058. PubMed ID: 35748782
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis, Necroptosis, and Pyroptosis in Gastrointestinal Cancers: The Chief Culprits of Tumor Progression and Drug Resistance.
Zhu X; Li S
Adv Sci (Weinh); 2023 Sep; 10(26):e2300824. PubMed ID: 37436087
[TBL] [Abstract][Full Text] [Related]
18. Identification and Verification of Necroptosis-Related Gene Signature With Prognosis and Tumor Immune Microenvironment in Ovarian Cancer.
Wang Z; Chen G; Dai F; Liu S; Hu W; Cheng Y
Front Immunol; 2022; 13():894718. PubMed ID: 35812403
[TBL] [Abstract][Full Text] [Related]
19. Clinical Implications of Necroptosis Genes Expression for Cancer Immunity and Prognosis: A Pan-Cancer Analysis.
Li XY; Su LX; Chen WX; Liu H; Zhang LY; Shen YC; You JX; Wang JB; Zhang L; Wang D; Wen MZ; Wang Z; Shao YH; Chen DH; Yang XT
Front Immunol; 2022; 13():882216. PubMed ID: 35795676
[TBL] [Abstract][Full Text] [Related]
20. Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer.
Luo W; Xiang W; Gan L; Che J; Li J; Wang Y; Han L; Gu R; Ye L; Wang R; Zhang X; Xu Y; Dai W; Mo S; Li Q; Cai G
J Transl Med; 2022 May; 20(1):235. PubMed ID: 35590418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]